Consensus EPS · Q2 2026
$1.28
Consensus revenue · Q2 2026
$1.1B
Analysts
9
Expected report
Jul 31, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 9 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $1.1B | $1.1B | $1.2B |
| EPS | $1.21 | $1.28 | $1.34 |
| EBITDA | $586.7M | $614.4M | $665.2M |
| EBIT | $518.9M | $543.4M | $588.4M |
| Net income | $266.6M | $286.2M | $299.3M |
- Revenue$1.1B
- EPS$1.28
- EBITDA$614.4M
- EBIT$543.4M
- Net income$286.2M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $1.3B | $1.3B | +0.9% | $1.24 | $1.33 | -7.0% |
- Q1 2026+0.9%-7.0%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Ares Management (ARES) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 3 analysts.
- Low
- $128.00
- Consensus
- $160.38
- Median
- $157.50
- High
- $215.00
- Current
- $119.57
- Upside
- +34.1%
Upside calculated vs most recent trading price of $119.57.
Analyst ratings
Consensus: Buy — based on 22 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 17, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Jul 13, 2026 | BMO Capital | maintain | Market Perform | Market Perform |
| Jul 9, 2026 | Citizens | maintain | Market Outperform | Market Outperform |
| Jul 9, 2026 | Barclays | maintain | Overweight | Overweight |
| Jun 23, 2026 | TD Cowen | maintain | Buy | Buy |
| May 18, 2026 | TD Cowen | maintain | Buy | Buy |
| May 4, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| May 4, 2026 | Barclays | maintain | Overweight | Overweight |
| Apr 28, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Apr 22, 2026 | Citizens | maintain | Market Outperform | Market Outperform |
- Jul 17, 2026OppenheimerOutperform
- Jul 13, 2026BMO CapitalMarket Perform
- Jul 9, 2026CitizensMarket Outperform
- Jul 9, 2026BarclaysOverweight
- Jun 23, 2026TD CowenBuy
- May 18, 2026TD CowenBuy
- May 4, 2026OppenheimerOutperform
- May 4, 2026BarclaysOverweight
- Apr 28, 2026JP MorganOverweight
- Apr 22, 2026CitizensMarket Outperform
Frequently asked questions
Ares Management (ARES) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.